SCHEMBL9984629

SCHEMBL9984629

CCCN1CCCCCCCCN2CCCN=C12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
USP2 O75604 1/20 0.40
INMT O95050 1/20 0.40
CYP1A2 P05177 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TSHR P16473 3/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 4/20 0.33
POLB P06746 1/20 0.33
ADORA1 P30542 2/20 0.33
KDM2B Q8NHM5 1/20 0.31
PDE4A P27815 2/20 0.30
PDE4B Q07343 2/20 0.30
PDE4C Q08493 2/20 0.30
PDE4D Q08499 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL251940 0.95 CYP2D6 (0.42) CYP2D6CYP3A4CYP2C19USP2INMT
SCHEMBL2740903 0.91 CYP2D6 (0.42) CYP2D6CYP3A4CYP2C19USP2INMT
SCHEMBL252415 0.84 CYP2D6 (0.44) CYP2D6CYP3A4CYP2C19USP2INMT
SCHEMBL8368647 0.83 ALDH1A1 (0.45) CYP2D6CYP3A4CYP2C19CYP1A2ALDH1A1
SCHEMBL253401 0.81 ALDH1A1 (0.47) CYP2D6CYP3A4CYP2C19CYP1A2ALDH1A1
SCHEMBL17217520 0.81 ALDH1A1 (0.47) CYP2D6CYP3A4CYP2C19CYP1A2ALDH1A1
SCHEMBL31066868 0.81 ALDH1A1 (0.47) CYP2D6CYP3A4CYP2C19CYP1A2ALDH1A1
SCHEMBL31066883 0.81 ALDH1A1 (0.47) CYP2D6CYP3A4CYP2C19CYP1A2ALDH1A1
SCHEMBL31066870 0.81 ALDH1A1 (0.47) CYP2D6CYP3A4CYP2C19CYP1A2ALDH1A1
SCHEMBL250783 0.81 ALDH1A1 (0.47) CYP2D6CYP3A4CYP2C19CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1930376-B2 CURABLE COMPOSITION KANEKA CORP (JP) 2016-09-07 EP disclosed
WO-2012036392-A3 HUMAN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR FAB ANTIBODY AND A PHARMACEUTICAL COMPOSITION FOR TREATING TUMOURS COMPRISING THE SAME 주식회사 아이지세라피 (KR) 2012-05-10 WO disclosed
EP-1930376-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2011-12-07 EP disclosed